Literature DB >> 19121090

Epithelioid angiomyolipoma of the kidney.

Ikuma Kato1, Yoshiaki Inayama, Shoji Yamanaka, Hisashi Ohshiro, Kiyoshi Gomi, Sumiko Shirai, Ichiro Aoki, Hiroji Uemura, Yasuhide Miyoshi, Yoshinobu Kubota, Masahiro Yao, Yoji Nagashima.   

Abstract

Epithelioid angiomyolipoma (eAMLoma) is an uncommon renal mesenchymal tumor with malignant potential and is frequently associated with tuberous sclerosis (TSC). It is composed of polygonal large-sized tumor cells arranged in an epithelioid manner. Differential diagnosis from renal cell carcinoma (RCC) is often challenging because of its epithelioid morphology. Herein is reported three cases of eAMLoma, involving one in a 28-year-old man with TSC and two in women without TSC (34 and 62 years of age, respectively). The male TSC patient had microscopic conventional AMLomas in the same kidney. All patients were positive for melanoma (reactive with HMB45 antibody, and positive for melan A, tyrosinase and microphthalmia transcription factor) and smooth muscle markers (positive for alpha-smooth muscle-specific actin), but not for epithelial markers (cytokeratin, epithelial membrane antigen). In particular, the translocation RCC is an important differential diagnostic candidate, in terms of the positive reaction with HMB45 and morphological similarity. The present tumor samples did not show any reactivity for transcription factor binding to IGHM enhancer 3 or transcription factor EB, which excluded the possibility of translocation RCC. The possibility of eAMLoma should be evaluated as a diagnostic candidate, especially in cases of renal tumors (i) in young patients; (ii) associated with TSC; or (iii) with an epithelioid morphology and a high nuclear grade.

Entities:  

Mesh:

Year:  2009        PMID: 19121090     DOI: 10.1111/j.1440-1827.2008.02322.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Clinicopathological analysis of 156 patients with angiomyolipoma originating from different organs.

Authors:  Lin Yang; Xiao-Li Feng; Steven Shen; Ling Shan; Hai-Feng Zhang; Xiu-Yun Liu; Ning Lv
Journal:  Oncol Lett       Date:  2012-01-03       Impact factor: 2.967

Review 2.  Targeted therapeutic strategies for the management of renal cell carcinoma.

Authors:  Eric A Singer; Gopal N Gupta; Ramaprasad Srinivasan
Journal:  Curr Opin Oncol       Date:  2012-05       Impact factor: 3.645

3.  Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas.

Authors:  Ozgür Mete; Yersu Kapran; Mine G Güllüoğlu; Işin Kiliçaslan; Yeşim Erbil; Yasemin Giles Senyürek; Ferhunde Dizdaroğlu
Journal:  Virchows Arch       Date:  2010-05       Impact factor: 4.064

4.  A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.

Authors:  Chisato Ohe; Naoto Kuroda; Ondrej Hes; Michal Michal; Tomas Vanecek; Petr Grossmann; Yukichi Tanaka; Mio Tanaka; Hidekazu Inui; Yoshihiro Komai; Tadashi Matsuda; Yoshiko Uemura
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

5.  Pigmented perivascular epithelioid cell tumor (PEComa) of the kidney: a case report and review of the literature.

Authors:  Hyeyoon Chang; Wonkyung Jung; Youngran Kang; Woon Yong Jung
Journal:  Korean J Pathol       Date:  2012-10-25

6.  Aggressive renal angiomyolipoma with vena cava extension: A case report and literature review.

Authors:  Gang Shen; Qiqi Mao; Hanjin Yang; Chaojun Wang
Journal:  Oncol Lett       Date:  2014-08-08       Impact factor: 2.967

7.  Tsc1 ablation in Prx1 and Osterix lineages causes renal cystogenesis in mouse.

Authors:  Zhixiang Wu; Hongguang Wu; Shafiquzzaman Md; Guo Yu; Samy L Habib; Baojie Li; Jing Li
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.